NOVARTIS GENE THERAPIES EU LIMITED, SUCURSAL EN ESPAÑA
Company details
- No Activa NIF/CIF: W0074353D
-
Telephone: Not available
-
Date of last BORME entry: 30/05/2023
-
Sector: Wholesale and Retail Trade; Except Repair of Motor Vehicles and Motorcycles
-
Address: P.º de la Castellana, 135, 7 floor, Tetuán, 28046 Madrid, España See in map
-
Website: Not available
-
Featured products:
More information on NOVARTIS GENE THERAPIES EU LIMITED, SUCURSAL EN ESPAÑA
-
JAIN MAYANK.ApoderadoAppointment: 30/05/2023Termination of employment: 30/05/2023 -
FOLGUEIRA LOPEZ MARIA ALICIA.DesconocidoTermination of employment: 30/05/2023
-
FOLGUEIRA LOPEZ MARIAALICIAApoderadoTermination of employment: 30/05/2023
-
VASSILIATHIS PANAGIOTIS.ApoderadoTermination of employment: 12/08/2022
-
FOLGUEIRA LOPEZ MARIA ALICIAApoderadoAppointment: 30/04/2019
-
FOLGUEIRA LOPEZ MARIA ALICIARelaciones permanentesAppointment: 30/04/2019
-
VASSILIATHIS PANAGIOTISApoderadoAppointment: 30/04/2019
-
30/05/2023 | BORME act no.: 244975 | Register: MADRIDNombramientos -
30/05/2023 | BORME act no.: 244975 | Register: MADRIDFe de erratas
-
30/05/2023 | BORME act no.: 244976 | Register: MADRIDCeses/Dimisiones
-
30/05/2023 | BORME act no.: 244976 | Register: MADRIDRevocaciones
-
30/05/2023 | BORME act no.: 244976 | Register: MADRIDDisolución
-
12/08/2022 | BORME act no.: 376577 | Register: MADRIDRevocaciones
-
12/08/2022 | BORME act no.: 376577 | Register: MADRIDOtros conceptos
-
13/01/2021 | BORME act no.: 13225 | Register: MADRIDOtros conceptos
-
04/11/2020 | BORME act no.: 377390 | Register: MADRIDCambio de denominación social
-
30/10/2020 | BORME act no.: 372955 | Register: MADRIDOtros conceptos
Other information
The CIF assigned to NOVARTIS GENE THERAPIES EU LIMITED, SUCURSAL EN ESPAÑA is W0074353D, and its commercial status is dissolved. The company carries out its operations within the CNAE 4646 - Wholesale of pharmaceutical products. Likewise, its SIC code - identifies it.
NOVARTIS GENE THERAPIES EU LIMITED, SUCURSAL EN ESPAÑA employs a team of Between 10 and 49 employees and records an annual turnover of less than 2 million euros. The entity is registered in the Mercantile Registry of Madrid and has 7 registration charges. The last announcement in Borme was published on 30/05/2023, while the most recent deposit of ordinary annual accounts is from the year 2020.
To access the contact information of NOVARTIS GENE THERAPIES EU LIMITED, SUCURSAL EN ESPAÑA, such as the phone number, address, or website, visit the Company Data module.
If you require additional information about NOVARTIS GENE THERAPIES EU LIMITED, SUCURSAL EN ESPAÑA, you can review one of our available financial reports, the Annual Accounts of the company, or verify its default incidents in the RAI delinquency file.
All the financial, commercial, and legal information we provide about NOVARTIS GENE THERAPIES EU LIMITED, SUCURSAL EN ESPAÑA comes from official sources and is regularly updated.
Do you want to know more about NOVARTIS GENE THERAPIES EU LIMITED, SUCURSAL EN ESPAÑA??
Find out more about this company by consulting these reports:
